Applied Energetics Inc. (AERG) Insider Trading

Last 12 months

Insiders sold $280k and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Jun 2007.

Net open-market

−$280k

0 buys · 17 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Jun 2007

Jun 29, 2007

Get an email when AERG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 8	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.50	$15k	0.4%	Form 4
Jun 1	Christopher Wayne Donaghey President & CEO	Sold10b5-1 plan	10,000	$1.50	$15k	8.1%	Form 4
May 11	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.50	$15k	0.4%	Form 4
May 11	Christopher Wayne Donaghey President & CEO	Sold10b5-1 plan	10,000	$1.50	$15k	7.5%	Form 4
Jan 26	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$1.65	$17k	7.0%	Form 4
Jan 21	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	6,600	$1.87	$12k	100%	Form 4
Jan 20	Stephen William McCahon Chief Science Officer	Sold10b5-1 plan	10,000	$1.80	$18k	<0.1%	Form 4
Jan 7	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.77	$18k	0.4%	Form 4
Dec 26, 2025 – Dec 29, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan 2 parts	10,000	$1.93 average	$19k	6.5%	Form 4
Dec 22, 2025	Stephen William McCahon Chief Science Officer	Sold10b5-1 plan	10,000	$1.86	$19k	<0.1%	Form 4
Dec 22, 2025	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	10,000	$1.88	$19k	100%	Form 4
Dec 8, 2025	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.86	$19k	0.4%	Form 4
Dec 4, 2025	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	10,000	$1.77	$18k	100%	Form 4
Nov 28, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$1.50	$15k	6.1%	Form 4
Nov 19, 2025 – Nov 21, 2025	Stephen William McCahon Chief Science Officer	Sold10b5-1 plan 2 parts	10,000	$1.51 average	$15k	<0.1%	Form 4
Nov 17, 2025	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.58	$16k	0.4%	Form 4
Oct 27, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$1.68	$17k	5.8%	Form 4
Oct 20, 2025	Stephen William McCahon Chief Science Officer	Sold10b5-1 plan	10,000	$1.65	$17k	<0.1%	Form 4
Sep 25, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$2.00	$20k	5.4%	Form 4
Sep 24, 2025	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	10,000	$1.92	$19k	100%	Form 4
Sep 19, 2025	Stephen William McCahon Chief Science Officer	Sold10b5-1 plan	10,000	$1.50	$15k	<0.1%	Form 4
Sep 19, 2025	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.50	$15k	0.4%	Form 4
Aug 15, 2025	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.76	$18k	0.4%	Form 4
Aug 5, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$1.98	$20k	5.2%	Form 4
Jul 21, 2025	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	10,000	$2.25	$23k	100%	Form 4
Jul 15, 2025	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$2.33	$23k	0.4%	Form 4
Jul 7, 2025 – Jul 8, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan 2 parts	10,000	$2.23 average	$22k	7.1%	Form 4
Jun 23, 2025	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	10,000	$2.16	$22k	100%	Form 4
Jun 12, 2025	Bradford Thomas Adamczyk Director	Sold10b5-1 plan	10,000	$1.87	$19k	0.4%	Form 4
Jun 5, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$2.33	$23k	6.6%	Form 4
May 28, 2025	Gregory James Quarles CEO Emeritus	Sold10b5-1 plan	10,000	$1.92	$19k	100%	Form 4
May 22, 2025	Bradford Thomas Adamczyk Executive Chairman	Sold10b5-1 plan	10,000	$1.50	$15k	0.4%	Form 4
May 21, 2025	Christopher Wayne Donaghey President & CEO/Principal AO	Sold10b5-1 plan	10,000	$1.50	$15k	6.2%	Form 4

Jun 810b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.50
$15k
0.4% of stake
Jun 110b5-1 plan
Christopher Wayne Donaghey
President & CEO · sold 10,000 at $1.50
$15k
8.1% of stake
May 1110b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.50
$15k
0.4% of stake
May 1110b5-1 plan
Christopher Wayne Donaghey
President & CEO · sold 10,000 at $1.50
$15k
7.5% of stake
Jan 2610b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $1.65
$17k
7.0% of stake
Jan 2110b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 6,600 at $1.87
$12k
100% of stake
Jan 2010b5-1 plan
Stephen William McCahon
Chief Science Officer · sold 10,000 at $1.80
$18k
<0.1% of stake
Jan 710b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.77
$18k
0.4% of stake
Dec 26, 2025 – Dec 29, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at avg $1.93
$19k
6.5% of stake
Dec 22, 202510b5-1 plan
Stephen William McCahon
Chief Science Officer · sold 10,000 at $1.86
$19k
<0.1% of stake
Dec 22, 202510b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 10,000 at $1.88
$19k
100% of stake
Dec 8, 202510b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.86
$19k
0.4% of stake
Dec 4, 202510b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 10,000 at $1.77
$18k
100% of stake
Nov 28, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $1.50
$15k
6.1% of stake
Nov 19, 2025 – Nov 21, 202510b5-1 plan
Stephen William McCahon
Chief Science Officer · sold 10,000 at avg $1.51
$15k
<0.1% of stake
Nov 17, 202510b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.58
$16k
0.4% of stake
Oct 27, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $1.68
$17k
5.8% of stake
Oct 20, 202510b5-1 plan
Stephen William McCahon
Chief Science Officer · sold 10,000 at $1.65
$17k
<0.1% of stake
Sep 25, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $2.00
$20k
5.4% of stake
Sep 24, 202510b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 10,000 at $1.92
$19k
100% of stake
Sep 19, 202510b5-1 plan
Stephen William McCahon
Chief Science Officer · sold 10,000 at $1.50
$15k
<0.1% of stake
Sep 19, 202510b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.50
$15k
0.4% of stake
Aug 15, 202510b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.76
$18k
0.4% of stake
Aug 5, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $1.98
$20k
5.2% of stake
Jul 21, 202510b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 10,000 at $2.25
$23k
100% of stake
Jul 15, 202510b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $2.33
$23k
0.4% of stake
Jul 7, 2025 – Jul 8, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at avg $2.23
$22k
7.1% of stake
Jun 23, 202510b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 10,000 at $2.16
$22k
100% of stake
Jun 12, 202510b5-1 plan
Bradford Thomas Adamczyk
Director · sold 10,000 at $1.87
$19k
0.4% of stake
Jun 5, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $2.33
$23k
6.6% of stake
May 28, 202510b5-1 plan
Gregory James Quarles
CEO Emeritus · sold 10,000 at $1.92
$19k
100% of stake
May 22, 202510b5-1 plan
Bradford Thomas Adamczyk
Executive Chairman · sold 10,000 at $1.50
$15k
0.4% of stake
May 21, 202510b5-1 plan
Christopher Wayne Donaghey
President & CEO/Principal AO · sold 10,000 at $1.50
$15k
6.2% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AERG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Search, Detection, Navigation, Guidance, Aeronautical Sys

NNNextNav Inc.

LYRALyra Therapeutics Inc.

STAIScantech AI Systems Inc.

AEMDAethlon Medical Inc.

GTHPGuided Therapeutics Inc.

POSCPositron Corporation

ENDVEndonovo Therapeutics Inc.

QURTQuarta-Rad Inc.

Spot a number that looks wrong? Check it in AERG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AERG

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.